# Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty

> **NCT03502018** · PHASE4 · COMPLETED · sponsor: **Maimonides Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Intracapsular Fracture of Femur
- Femoral Neck Fractures
- Hip Hemiarthroplasty

## Interventions

- **DRUG:** Bupivacaine liposome
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03502018
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03502018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03502018, "Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03502018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*